Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Finished Goods (2020 - 2025)

Maravai Lifesciences Holdings has reported Finished Goods over the past 6 years, most recently at $18.6 million for Q4 2025.

  • Quarterly results put Finished Goods at $18.6 million for Q4 2025, down 19.46% from a year ago — trailing twelve months through Dec 2025 was $18.6 million (down 19.46% YoY), and the annual figure for FY2025 was $18.6 million, down 19.46%.
  • Finished Goods for Q4 2025 was $18.6 million at Maravai Lifesciences Holdings, down from $19.6 million in the prior quarter.
  • Over the last five years, Finished Goods for MRVI hit a ceiling of $23.1 million in Q4 2024 and a floor of $6.3 million in Q2 2021.
  • Median Finished Goods over the past 5 years was $12.9 million (2021), compared with a mean of $14.6 million.
  • Biggest five-year swings in Finished Goods: dropped 26.16% in 2022 and later surged 185.77% in 2024.
  • Maravai Lifesciences Holdings' Finished Goods stood at $10.4 million in 2021, then fell by 26.16% to $7.7 million in 2022, then surged by 151.15% to $19.4 million in 2023, then grew by 18.98% to $23.1 million in 2024, then fell by 19.46% to $18.6 million in 2025.
  • The last three reported values for Finished Goods were $18.6 million (Q4 2025), $19.6 million (Q3 2025), and $19.7 million (Q2 2025) per Business Quant data.